Literature DB >> 17082767

Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome.

Ivana De Domenico1, Michael B Vaughn, Liangtao Li, Dustin Bagley, Giovanni Musci, Diane M Ward, Jerry Kaplan.   

Abstract

Ferritin is a cytosolic molecule comprised of subunits that self-assemble into a nanocage capable of containing up to 4500 iron atoms. Iron stored within ferritin can be mobilized for use within cells or exported from cells. Expression of ferroportin (Fpn) results in export of cytosolic iron and ferritin degradation. Fpn-mediated iron loss from ferritin occurs in the cytosol and precedes ferritin degradation by the proteasome. Depletion of ferritin iron induces the monoubiquitination of ferritin subunits. Ubiquitination is not required for iron release but is required for disassembly of ferritin nanocages, which is followed by degradation of ferritin by the proteasome. Specific mammalian machinery is not required to extract iron from ferritin. Iron can be removed from ferritin when ferritin is expressed in Saccharomyces cerevisiae, which does not have endogenous ferritin. Expressed ferritin is monoubiquitinated and degraded by the proteasome. Exposure of ubiquitination defective mammalian cells to the iron chelator desferrioxamine leads to degradation of ferritin in the lysosome, which can be prevented by inhibitors of autophagy. Thus, ferritin degradation can occur through two different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082767      PMCID: PMC1636618          DOI: 10.1038/sj.emboj.7601409

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome.

Authors:  Reshma Shringarpure; Tilman Grune; Jana Mehlhase; Kelvin J A Davies
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

2.  Oxidation-induced ferritin turnover in microglial cells: role of proteasome.

Authors:  Jana Mehlhase; Grit Sandig; Kostas Pantopoulos; Tilman Grune
Journal:  Free Radic Biol Med       Date:  2005-01-15       Impact factor: 7.376

3.  Ferritins: dynamic management of biological iron and oxygen chemistry.

Authors:  Xiaofeng Liu; Elizabeth C Theil
Journal:  Acc Chem Res       Date:  2005-03       Impact factor: 22.384

4.  Structure and physiological functions of ferritin.

Authors:  S GRANICK
Journal:  Physiol Rev       Date:  1951-10       Impact factor: 37.312

5.  "Opening" the ferritin pore for iron release by mutation of conserved amino acids at interhelix and loop sites.

Authors:  W Jin; H Takagi; B Pancorbo; E C Theil
Journal:  Biochemistry       Date:  2001-06-26       Impact factor: 3.162

Review 6.  Deferoxamine pharmacokinetics.

Authors:  J B Porter
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

7.  Ferritin oxidation in vitro: implication of iron release and degradation by the 20S proteasome.

Authors:  M Rudeck; T Volk; N Sitte; T Grune
Journal:  IUBMB Life       Date:  2000-05       Impact factor: 3.885

8.  CCC1 is a transporter that mediates vacuolar iron storage in yeast.

Authors:  L Li; O S Chen; D McVey Ward; J Kaplan
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

9.  Enhanced iron uptake of Saccharomyces cerevisiae by heterologous expression of a tadpole ferritin gene.

Authors:  Y M Shin; T H Kwon; K S Kim; K S Chae; D H Kim; J H Kim; M S Yang
Journal:  Appl Environ Microbiol       Date:  2001-03       Impact factor: 4.792

10.  Release of iron from ferritin requires lysosomal activity.

Authors:  Theodros Z Kidane; Eric Sauble; Maria C Linder
Journal:  Am J Physiol Cell Physiol       Date:  2006-04-12       Impact factor: 4.249

View more
  73 in total

1.  Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages.

Authors:  Carole Beaumont
Journal:  Haematologica       Date:  2010-08       Impact factor: 9.941

2.  Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate.

Authors:  Daniel Kim; Jens H Jensen; Ed X Wu; Li Feng; Wing-Yan Au; Jerry S Cheung; Shau-Yin Ha; Sujit S Sheth; Gary M Brittenham
Journal:  NMR Biomed       Date:  2010-12-28       Impact factor: 4.044

3.  The core control system of intracellular iron homeostasis: a mathematical model.

Authors:  J Chifman; A Kniss; P Neupane; I Williams; B Leung; Z Deng; P Mendes; V Hower; F M Torti; S A Akman; S V Torti; R Laubenbacher
Journal:  J Theor Biol       Date:  2012-01-23       Impact factor: 2.691

Review 4.  Cellular and mitochondrial iron homeostasis in vertebrates.

Authors:  Caiyong Chen; Barry H Paw
Journal:  Biochim Biophys Acta       Date:  2012-01-18

Review 5.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

6.  Ferritin contains less iron (59Fe) in cells when the protein pores are unfolded by mutation.

Authors:  Mohammad R Hasan; Takehiko Tosha; Elizabeth C Theil
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

Review 7.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

Review 8.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

9.  Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells.

Authors:  Takeshi Asano; Masaaki Komatsu; Yuko Yamaguchi-Iwai; Fuyuki Ishikawa; Noboru Mizushima; Kazuhiro Iwai
Journal:  Mol Cell Biol       Date:  2011-03-28       Impact factor: 4.272

10.  Iron increases the susceptibility of multiple myeloma cells to bortezomib.

Authors:  Alessandro Campanella; Paolo Santambrogio; Francesca Fontana; Michela Frenquelli; Simone Cenci; Magda Marcatti; Roberto Sitia; Giovanni Tonon; Clara Camaschella
Journal:  Haematologica       Date:  2012-12-14       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.